Eventide Asset Management - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 185 filers reported holding SAGE THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$22,689,000
-60.2%
790,0000.0%0.74%
-54.3%
Q4 2019$57,030,000
-48.5%
790,0000.0%1.61%
-56.1%
Q3 2019$110,829,000
-19.8%
790,000
+4.6%
3.66%
-12.9%
Q2 2019$138,233,000
+8.0%
755,000
-6.2%
4.20%
-4.6%
Q1 2019$128,035,000
+42.8%
805,000
-14.0%
4.41%
+11.0%
Q4 2018$89,659,000
+28.5%
936,000
+89.5%
3.97%
+54.9%
Q3 2018$69,778,000
+20.5%
494,000
+33.5%
2.56%
+6.6%
Q2 2018$57,916,000
+43.8%
370,000
+48.0%
2.40%
+27.5%
Q1 2018$40,268,000
-14.1%
250,000
-12.2%
1.88%
-22.9%
Q4 2017$46,876,000
+373.2%
284,600
+79.0%
2.44%
+335.7%
Q3 2017$9,906,000
+53.6%
159,000
+96.3%
0.56%
+39.6%
Q2 2017$6,451,000
+12.1%
81,0000.0%0.40%
+5.5%
Q1 2017$5,757,000
-33.7%
81,000
-52.4%
0.38%
-32.6%
Q4 2016$8,680,000
+10.9%
170,0000.0%0.56%
+18.2%
Q3 2016$7,829,000
+52.9%
170,0000.0%0.48%
+52.7%
Q2 2016$5,122,000
-6.0%
170,0000.0%0.31%
+2.6%
Q1 2016$5,450,000
-25.7%
170,000
+35.0%
0.30%
-16.9%
Q4 2015$7,340,000
+45.5%
125,900
+5.6%
0.37%
+25.3%
Q3 2015$5,045,000
+71.9%
119,200
+196.5%
0.29%
+84.3%
Q2 2015$2,935,000
+45.4%
40,2000.0%0.16%
+4.6%
Q1 2015$2,019,000
+37.3%
40,2000.0%0.15%
-5.6%
Q4 2014$1,471,000
+16.2%
40,2000.0%0.16%
-9.0%
Q3 2014$1,266,00040,2000.18%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders